GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) to treat chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.

true

Take a step with GAMMAGARD LIQUID

Talk to your doctor to find out if GAMMAGARD LIQUID is right for you.

A therapy to improve neuromuscular disability and impairment in adult patients with CIDP.

An IG therapy for adults with CIDP

Living with the symptoms of a chronic neurological disease can make even everyday activities a struggle.

GAMMAGARD LIQUID, a widely known IG therapy, may be used to help treat your CIDP to improve neuromuscular disability and impairment.

94% of people in the CIDP clinical study (17 out of 18 patients) experienced improvement on a measure of arm and leg disability after 6 months of treatment.*

*18 CIDP patients, who had relapsed in a previous study phase, received GAMMAGARD LIQUID treatment.

Learn about GAMMAGARD LIQUID for CIDP

Vial icon.

What makes GAMMAGARD LIQUID an established IVIG therapy?

Medical cross icon.

How did CIDP patients tolerate GAMMAGARD LIQUID?

IVIG bag icon.

How can GAMMAGARD LIQUID fit into your schedule?

GAMMAGARD LIQUID CIDP Patient Brochure.

Looking for more information about CIDP and working with your doctor to create a treatment plan?

The GAMMAGARD LIQUID Treatment Brochure provides detailed facts of CIDP and how GAMMAGARD LIQUID may be a treatment option. Download this brochure to discuss with your doctor.

Checkmark inside a diamond icon.

Another IG treatment option

There’s an IG therapy option that’s infused subcutaneously with a flexible dosing schedule.
Talk to your doctor to determine which treatment could be right for you.